Clinical Trial Update: Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

View source ↗

Summary

This clinical trial update investigates how the absence of CMV-specific CD8+ T cell responses in CMV-seropositive donors may affect CMV reactivation after hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Cytomegalovirus Infection, HSCT | Status: UNKNOWN